Supplementary Data 1
Test protocol for the DOI method
For the DOI approach according to Zorn-Kruppa et al., 2014, 50 µL or 50 mg, respectively, of the test items were topically applied onto the hemicornea tissues. After a 60 minutes exposure time at room temperature, the remaining chemicals were thoroughly rinsed off the surface with phosphate-buffered saline PBS. Then the tissues were transferred into 1.5 mL MTT solution (1 mg/mL) and incubated for 2 h at 37°C and 5% CO2. Sucrose solution was added to a final concentration of 20% and incubation continued for another 60 min. After this 3 hours incubation period the tissues were removed from the inserts, transferred into cryomolds and embedded in cryomatrix embedding resin (e.g. Thermo Scientific, UK). The tissues were then placed at 4°C for 30 minutes and afterwards frozen in the gaseous phase above liquid nitrogen. The frozen tissues were stored at -20°C prior to cryosectioning. The cornea models were cut into sections of 30 µm thickness with a cryomicrotome at a chamber temperature of -23 to -25°C and object temperature of -19°C to -21°C. From each sample 3 sections were cut from the center of the models and transferred to glass slides, where they were preserved in Fluoromount G medium (e.g. Southern Biotech, USA).
For the determination of the DOI the light-microscopical images of the sections were processed with ImageJ freeware (Schneider; 2012). The total cross-sectional lengths and the formazan-stained tissue lengths were measured 5 times per section. The relative DOI (rMTT-DOI) was calculated as percentage of the non-viable tissue thickness, where no formazan staining was present, of the total tissue thickness.
The prediction model is based on two rDOI cut-off values: test chemicals which induce rMTT-DOI of ≤5% were classified as UN GHS No Category; test chemicals which induce rMTT-DOI of ≥90% were categorized as UN GHS Category 1; all others with the intermediate rMTT-DOI were classified as UN GHS Category 2.
Test protocol for the CCC method
For the CCC method according to Bartok et al., 2015, 50 µL or 50 mg, respectively, of the test items were topically applied onto the epithelium in an O-ring. After exposure, the tissues were washed intensively with PBS and the Orings were removed from the tissues. For the MTT viability assay the CCC membrane with the epithelial layer was separated from the stroma with forceps. The epithelial and stromal parts were transferred into individual wells of a 24well plate in order to to assess stroma and epithelium individually.
To determine tissue viability 1.5 mL MTT solution (1 mg/mL) were added to each tissue. After 3 hours incubation at 37°C the MTT solution was removed and the tissues were transferred into 1.5 mL 2-propanol for formazan extration. The formazan content of the extract was then determined via its optical density (OD) in a spectrophotometer. Relative tissue viability was calculated from the OD as a percentage of the negative control (equals 100% viability) for each sample.
The prediction model is based on the relative viabilities (%) from both the epithelium and the stroma after chemical treatment. The differentiation of all GHS categories of tested chemicals was based on appropriate viability cut-off values set for both epithelium and stroma. According to Bartok et al. (2015) , a chemical with the epithelial and stromal viability of >15% and >35%, respectively, was classified as UN GHS No Category, a chemical with <15% epithelial viability and >35% stromal viability was categorized as UN GHS Category 2 and a chemical with <35% stromal viability was classified as UN GHS Category 1.
Chemicals selection
The test chemicals were selected according to the following criteria: i) they must cover all 3 GHS categories, ii) they must belong to different chemical classes with different reactive groups, III) their in vivo-classification is based on different effects on the ocular tissues, iv) they were not used in the training set, and v) they must be commercially available. The selection is listed in Table S1 : 
